DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Gottlieb AB, Blauvelt A, Prinz JC. et al.
Secukinumab self-administration by prefilled syringe maintains reduction of plaque psoriasis severity over 52 weeks: Results of the FEATURE trial.
J Drugs Dermatol 2016;
15: 1226-1234
Access:
We do not assume any responsibility for the contents of the web pages of other providers.